logo

Akers Biosciences, Inc. (AKER)



Trade AKER now with
  Date
  Headline
11/15/2018 7:08:36 AM Akers Biosciences Q3 Net Loss Attributable To Shareholders $3.08 Mln; Total Revenue $0.56 Mln
11/7/2018 9:17:41 AM Akers Biosciences Intends To Explore Strategic Alternatives; Plans 1:8 Reverse Stock Split
7/18/2018 7:04:36 AM Akers Biosciences Signs A Further Independent Sales Representative Organization For Heparin PF4 Rapid Test
6/29/2018 7:05:09 AM Akers Biosciences Requests Temporary Suspension Of Trading On London Stock Exchange
5/29/2018 7:04:46 AM Akers Biosciences Withdraws FDA 510(k) Submission For PIFA Chlamydia Rapid Assay Pending Further Evaluation
4/12/2018 7:12:47 AM Akers Biosciences Expands Outsourced US Distribution Capabilities For Heparin PF4 Rapid Test
4/3/2018 7:14:25 AM Akers Biosciences 2017 Total Revenue Up 33% To $3.93 Mln
3/26/2018 7:03:25 AM Akers Biosciences Signs US Distribution Agreement With Diagnostica Stago
  
 
>